The 1298A→C polymorphism in methylenetetrahydrofolate reductase (MTHFR): in vitro expression and association with homocysteine
Top Cited Papers
- 1 June 2001
- journal article
- research article
- Published by Elsevier in Atherosclerosis
- Vol. 156 (2) , 409-415
- https://doi.org/10.1016/s0021-9150(00)00671-7
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- MTHFR association with arteriosclerotic vascular disease?Human Genetics, 1998
- A Second Genetic Polymorphism in Methylenetetrahydrofolate Reductase (MTHFR) Associated with Decreased Enzyme ActivityMolecular Genetics and Metabolism, 1998
- Homocysteine and Cardiovascular DiseaseAnnual Review of Medicine, 1998
- Correlation of a Common Mutation in the Methylenetetrahydrofolate Reductase Gene With Plasma Homocysteine in Patients With Premature Coronary Artery DiseaseArteriosclerosis, Thrombosis, and Vascular Biology, 1997
- Directed Mutagenesis Using the Polymerase Chain ReactionCurrent Protocols in Molecular Biology, 1997
- A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakesPublished by American Medical Association (AMA) ,1995
- A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductaseNature Genetics, 1995
- Human methylenetetrahydrofolate reductase: isolation of cDNA, mapping and mutation identificationNature Genetics, 1994
- Amino acid similarity coefficients for protein modeling and sequence alignment derived from main-chain folding anglesJournal of Molecular Biology, 1991
- Hyperhomocysteinemia: An Independent Risk Factor for Vascular DiseaseNew England Journal of Medicine, 1991